Skip to content
LexBuild

Title 21, Part 860 — Medical Device Classification Procedures

23 sections

Section 860.1
Scope.
Section 860.3
Definitions.
Section 860.5
Confidentiality and use of data and information submitted in connection with classification and reclassification.
Section 860.7
Determination of safety and effectiveness.
Section 860.10
Implants and life-supporting or life-sustaining devices.
Section 860.15
Exemptions from sections 510, 519, and 520(f) of the Federal Food, Drug, and Cosmetic Act.
Section 860.84
Classification procedures for “preamendments devices.”
Section 860.90
Consultation with panels.
Section 860.120
General.
Section 860.123
Reclassification petition: Content and form.
Section 860.125
Consultation with panels.
Section 860.130
General procedures under section 513(e) of the Federal Food, Drug, and Cosmetic Act.
Section 860.132
Procedures when the Commissioner initiates a performance standard or premarket approval proceeding under section 514(b) or 515(b) of the Federal Food, Drug, and Cosmetic Act.
Section 860.133
Procedures when the Commissioner initiates a proceeding to require premarket approval under section 515(b) of the Federal Food, Drug, and Cosmetic Act.
Section 860.134
Procedures for reclassification of “postamendments devices” under section 513(f)(3) of the Federal Food, Drug, and Cosmetic Act.
Section 860.136
Procedures for transitional products under section 520(l) of the Federal Food, Drug, and Cosmetic Act.
Section 860.200
Purpose and applicability.
Section 860.210
De Novo request format.
Section 860.220
De Novo request content.
Section 860.230
Accepting a De Novo request.
Section 860.240
Procedures for review of a De Novo request.
Section 860.250
Withdrawal of a De Novo request.
Section 860.260
Granting or declining a De Novo request.